• No results found

Cover Page The handle

N/A
N/A
Protected

Academic year: 2021

Share "Cover Page The handle"

Copied!
8
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

The handle

http://hdl.handle.net/1887/80398

holds various files of this Leiden University

dissertation.

Author: Gogola, E.

Title: Resistance to PARP inhibition by DNA damage response alterations in

BRCA1/2-deficient tumors

(2)

Resistance to PARP inhibition by DNA damage response

alterations in BRCA1/2-deficient tumors

(3)

Cover design: Krzysztof Marciniak, Graphic Design and Visual Communication Thesis lay-out: Gildeprint, Enschede

Printing: Gildeprint, Enschede

The printing of the thesis was financially supported by the NKI-AVL. © Copyright, Ewa Gogola, 2019

ISBN: 978-94-6323-904-2

(4)

Resistance to PARP inhibition by DNA damage response

alterations in BRCA1/2-deficient tumors

Proefschrift ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus prof.mr. C.J.J.M. Stolker,

volgens besluit van het College voor Promoties te verdedigen op dinsdag 12 november 2019

klokke 13.45 uur

(5)

Promotiecommisie: Prof.dr. H. Irth, voorzitter Prof.dr. J.A. Bouwstra, secretaris Prof. dr. Haico van Attikum Prof. dr. Marcel Tijsterman Dr. Maaike Vreeswijk

(6)
(7)
(8)

TABLE OF CONTENTS

Chapter 1 Scope of the thesis 9

Chapter 2 General introduction: Resistance to PARP inhibitors: lessons from 17 preclinical models of BRCA-associated cancer

Annual Review of Cancer Biology. 2019; Vol. 3:235-254

Chapter 3 BRCA-deficient mouse mammary tumor organoids - a tool to study 43 cancer drug resistance

Nature Methods. 2018; 15(2):134-140

Chapter 4 REV7 counteracts DNA double-strand break resection and affects 77 PARP inhibition

Nature. 2015; 521(7553):541-544

Chapter 5 Homologous recombination is frequently restored in BRCA1- but not 115 BRCA2-deficient tumors that acquired PARP inhibitor resistance

In preparation

Chapter 6 Replication fork stability confers chemoresistance in BRCA-deficient 147 cells

Nature. 2016; 535(7612):382-7

Chapter 7 Selective loss of PARG restores PARylation and counteracts PARP 187 inhibitor-mediated synthetic lethality

Cancer Cell. 2018; 33(6):1078-1093

Chapter 8 General conclusions and discussion 243

Appendices English summary 259

Nederlandse samenvatting 261

Curriculum vitae 263

Referenties

GERELATEERDE DOCUMENTEN

The research described in this thesis was performed at the Division of Tumor Biology of the Netherlands Cancer Institute (NKI/AvL) and supported by The Netherlands Organization

The research described in this thesis was performed at the Division of Cell Biology of the Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands.. Financial support

Bij dit overleg zijn twee dames van business intelligence (BI) betrokken die de cijfers van het ziekenhuis uit het ZIS halen t.b.v. We nemen alle indicatoren door die voor

The research described in this thesis was performed at the division of Immunology and at the division of Tumor Biology & Immunology of the Netherlands Cancer Institute – Antoni

The research described in this thesis was performed at the Department of Immunology at the Netherlands Cancer institute (NKI-AVL) and was financially supported

The research described in this thesis was performed at the Department of Cell Biology II at the Netherlands Cancer Institute (Antoni van Leeuwenhoek Ziekenhuis, NKI/AvL) under

The research described in this thesis was performed at the Division of Cell Biology I and Division of Molecular Genetics of the Netherlands Cancer Institute, Amsterdam,

The research described in this thesis was performed at the Divisions of Molecular Biology and Immunology of the Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital